Ticagrelor Monotherapy After PCI in High-Risk Patients With Prior MI

Autor: Mauro Chiarito, Usman Baber, Davide Cao, Samin K. Sharma, George Dangas, Dominick J. Angiolillo, Carlo Briguori, David J. Cohen, Dariusz Dudek, Vladimír Džavík, Javier Escaned, Robert Gil, Christian W. Hamm, Timothy Henry, Kurt Huber, Adnan Kastrati, Upendra Kaul, Ran Kornowski, Mitchell Krucoff, Vijay Kunadian, Shamir R. Mehta, David Moliterno, E. Magnus Ohman, Keith Oldroyd, Gennaro Sardella, Zhang Zhongjie, Samantha Sartori, Giulio Stefanini, Richard Shlofmitz, P. Gabriel Steg, Giora Weisz, Bernhard Witzenbichler, Ya-ling Han, Stuart Pocock, C. Michael Gibson, Roxana Mehran

Publikováno v: JACC: Cardiovascular Interventions. 15:282-293

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::f086139214f3d855e121a442d7c57f5c
https://doi.org/10.1016/j.jcin.2021.11.005

Ticagrelor Monotherapy Versus Dual-Antiplatelet Therapy After PCI

Autor: Marco Valgimigli, Roxana Mehran, Anna Franzone, Bruno R. da Costa, Usman Baber, Raffaele Piccolo, Eùgene P. McFadden, Pascal Vranckx, Dominick J. Angiolillo, Sergio Leonardi, Davide Cao, George D. Dangas, Shamir R. Mehta, Patrick W. Serruys, C. Michael Gibson, Gabriel P. Steg, Samin K. Sharma, Christian Hamm, Richard Shlofmitz, Christoph Liebetrau, Carlo Briguori, Luc Janssens, Kurt Huber, Maurizio Ferrario, Vijay Kunadian, David J. Cohen, Aleksander Zurakowski, Keith G. Oldroyd, Han Yaling, Dariuz Dudek, Samantha Sartori, Brian Kirkham, Javier Escaned, Dik Heg, Stephan Windecker, Stuart Pocock, Peter Jüni, Patrick Serruys, Shamir Mehta, Michael C. Gibson, Adnan Kastrati, Mitchel Krucoff, Magnus E. Ohman, Paul Gurbel, Timothy D. Henry, David Moliterno, Dierik Heg, Eugene McFadden, Steven O. Marx, Bruce Darrow, Nicola Corvaja, Douglas DeStefano, Newsha Ghodsi, Jose Meller, Theresa Franklin-Bond, Jin Young Cha, Zaha Waseem, Giora Weisz, Ran Kornowski, Keith Oldroyd, Upendra Kaul, Bernhard Witzenbichler, Vladimir Dzavik, Robert Gil, Gennaro Sardella, Edouard Benit, Roberto Diletti, Marcello Dominici, Ton Slagboom, Paweł Buszman, Leonardo Bolognese, Carlo Tumscitz, Krzysztof Bryniarski, Adel Aminian, Mathias Vrolix, Ivo Petrov, Scot Garg, Christoph Naber, Janusz Prokopczuk, Philippe Gabriel Steg

Publikováno v: JACC: Cardiovascular Interventions. 14:444-456

Objectives The aim of this study was to compare ticagrelor monotherapy with dual-antiplatelet therapy (DAPT) after percutaneous coronary intervention (PCI) with drug-eluting stents. Background The role of abbreviated DAPT followed by an oral P2Y12 in

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::a479460207337eabe05adc0bcafb2a2a
https://doi.org/10.1016/j.jcin.2020.11.046

TCT-13 Ticagrelor Monotherapy in Patients With Peripheral Artery Disease Undergoing PCI

Autor: Alessandro Spirito, Davide Cao, Samantha Sartori, Zhongjie Zhang, Johny Nicolas, David Cohen, Dominick Angiolillo, Carlo Briguori, Birgit Vogel, Timothy Collier, Dariusz Dudek, Javier Escaned, Samin Sharma, Serdar Farhan, Kurt Huber, Adnan Kastrati, Ran Kornowski, Mitchell Krucoff, Vijay Kunadian, Shamir Mehta, David Moliterno, E. Magnus Ohman, Gennaro Sardella, Richard Shlofmitz, Philippe Steg, Bernhard Witzenbichler, Yaling Han, Stuart Pocock, George Dangas, Roxana Mehran

Publikováno v: Journal of the American College of Cardiology. 80:B6

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::154887d88f9af446cdf31ad2f8c93c4c
https://doi.org/10.1016/j.jacc.2022.08.022

Incidence, predictors, and outcomes of DAPT disruption due to non-compliance vs. bleeding after PCI: insights from the PARIS Registry

Autor: George Dangas, David Moliterno, Roxana Mehran, Alaide Chieffo, Kamilia Moalem, Stuart J. Pocock, Samantha Sartori, Bimmer E. Claessen, Antonio Colombo, Mitchell W. Krucoff, Usman Baber, Michael C. Gibson, Ioannis Iakovou, A. Kini, Bernhard Witzenbichler, Melissa Aquino, Jaya Chandrasekhar

Publikováno v: Clinical Research in Cardiology. 108:643-650

The disruption of dual antiplatelet therapy (DAPT) due to non-compliance or bleeding is known to significantly increase the risk of adverse outcomes after percutaneous coronary intervention (PCI). However, it is currently unknown if there are differe

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::561601dd67571f3335a823ceeb47b20a
https://doi.org/10.1007/s00392-018-1392-2

DUAL ANTIPLATELET THERAPY (DAPT) CESSATION AND CARDIOVASCULAR RISK IN RELATION TO AGE: ANALYSIS FROM THE PARIS (PATTERNS OF NON-ADHERENCE TO ANTI-PLATELET REGIMENS IN STENTED PATIENTS) REGISTRY

Autor: Bimmer E. Claessen, Timothy Henry, Antonio Colombo, Mitchell W. Krucoff, C. Michael Gibson, David Moliterno, Sabato Sorrentino, Roxana Mehran, Alaide Chieffo, Giora Weisz, Philippe Gabriel Steg, Birgit Vogel, Bernhard Witzenbichler, Lauren Joyce, Usman Baber, Paul Guedeney, Michela Faggioni, Samantha Sartori, David Cohen, Jaya Chandrasekhar, Annapoorna Kini, Stuart J. Pocock, Cono Ariti, Melissa Aquino, George Dangas

Publikováno v: Journal of the American College of Cardiology. 73:1263

The examination of outcomes by age in percutaneous coronary intervention (PCI) is relevant given the aging population. We evaluated associations between DAPT cessation and cardiovascular (CV) risk after PCI in relation to age. PARIS was a prospective

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::338785c05c9e81017b0ff791f6ed0dd0
https://doi.org/10.1016/s0735-1097(19)31870-4